Use cautionDrug recall · FDA · Published December 23, 2020
Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk
Fresenius Kabi recalls Ketorolac injection vials due to particulate matter found in some samples. This may cause serious injury if injected. Check your vial's lot number and contact the company for details.
“Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36568-fresenius-kabi-ketorolac-injection-recall-particulate-matter-risk. Based on FDA recall #D-0245-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0245-2021%22&limit=1).
The FDA announced on December 23, 2020, that Fresenius Kabi USA, LLC voluntarily recalled Ketorolac Tromethamine Injection due to the presence of particulate matter in reserve sample vials. The recall affects 945,425 vials distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Fresenius Kabi
Product: Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01)
Lot #: 6121083
Expiration: 2/2021
Quantity: 945,425 vials
The hazard
The recall was initiated because particulate matter was found in reserve sample vials of the drug. The FDA classified this as a Class I recall, indicating a high risk of serious adverse health consequences or death.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has had 65 other recalls on record since September 27, 2012. Recent similar recalls include a Tyenne Injection recall for glass particles on August 10, 2026, and an Xylocaine 1% Injection recall for hair particulate matter on July 16, 2026. Other recent recalls of similar products include a Ketamine HCl Injection recall for lack of sterility assurance on February 5, 2026, a Lactated Ringer's Injection recall for particulate matter on April 28, 2026, and a Papaverine HCl Injection recall for particulate matter on July 24, 2026.
How to tell if you have this one
Check for vials labeled 'Ketorolac Tromethamine Injection, USP, 30 mg per mL' with NDC 63323-162-00 or 63323-162-01. The lot number is 6121083 with an expiration date of February 2021.
Brand
Fresenius Kabi
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Lot Number
Look for lot number 6121083 on the vial label. This is the specific batch affected by the particulate matter issue.
Contact Manufacturer
Reach out to Fresenius Kabi at Lake Zurich, IL 60047 for further assistance or to report concerns about the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0245-2021 (December 23, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0245-2021 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.